327 related articles for article (PubMed ID: 17065181)
21. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.
Sitbon O; McLaughlin VV; Badesch DB; Barst RJ; Black C; Galiè N; Humbert M; Rainisio M; Rubin LJ; Simonneau G
Thorax; 2005 Dec; 60(12):1025-30. PubMed ID: 16055621
[TBL] [Abstract][Full Text] [Related]
22. Outcomes in children with idiopathic pulmonary arterial hypertension.
Yung D; Widlitz AC; Rosenzweig EB; Kerstein D; Maislin G; Barst RJ
Circulation; 2004 Aug; 110(6):660-5. PubMed ID: 15289375
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
24. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.
Sitbon O; Humbert M; Nunes H; Parent F; Garcia G; Hervé P; Rainisio M; Simonneau G
J Am Coll Cardiol; 2002 Aug; 40(4):780-8. PubMed ID: 12204511
[TBL] [Abstract][Full Text] [Related]
25. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
Nakayama T; Ishikita T; Matsuura H; Saji T
J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
[TBL] [Abstract][Full Text] [Related]
26. EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension.
Sitbon O; Delcroix M; Bergot E; Boonstra AB; Granton J; Langleben D; Subías PE; Galiè N; Pfister T; Lemarié JC; Simonneau G
Am Heart J; 2014 Feb; 167(2):210-7. PubMed ID: 24439982
[TBL] [Abstract][Full Text] [Related]
27. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol.
Kuhn KP; Byrne DW; Arbogast PG; Doyle TP; Loyd JE; Robbins IM
Am J Respir Crit Care Med; 2003 Feb; 167(4):580-6. PubMed ID: 12446266
[TBL] [Abstract][Full Text] [Related]
28. Impact of switching from epoprostenol to IV treprostinil on treatment satisfaction and quality of life in patients with pulmonary hypertension.
Minai OA; Parambil J; Dweik RA; Davila GH; Peterson L; Rollins KD; Chen H
Respir Med; 2013 Mar; 107(3):458-65. PubMed ID: 23266038
[TBL] [Abstract][Full Text] [Related]
29. Continuous intravenous epoprostenol in pulmonary hypertension: the Israel experience.
Bendayan D; Fink G; Aravot D; Ygla M; Bendov I; Bliden L; Nir A; Kramer MR
Isr Med Assoc J; 2002 Apr; 4(4):255-8. PubMed ID: 12001697
[TBL] [Abstract][Full Text] [Related]
30. Living-donor lobar lung transplantation for pulmonary arterial hypertension after failure of epoprostenol therapy.
Date H; Kusano KF; Matsubara H; Ogawa A; Fujio H; Miyaji K; Okazaki M; Yamane M; Toyooka S; Aoe M; Sano Y; Hanazaki M; Goto K; Kasahara S; Sano S; Ohe T
J Am Coll Cardiol; 2007 Aug; 50(6):523-7. PubMed ID: 17678735
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral.
Badagliacca R; Pezzuto B; Poscia R; Mancone M; Papa S; Marcon S; Valli G; Sardella G; Ferrante F; Iacoboni C; Parola D; Fedele F; Vizza CD
J Heart Lung Transplant; 2012 Apr; 31(4):364-72. PubMed ID: 22289484
[TBL] [Abstract][Full Text] [Related]
32. Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment.
Fisher KA; Serlin DM; Wilson KC; Walter RE; Berman JS; Farber HW
Chest; 2006 Nov; 130(5):1481-8. PubMed ID: 17099027
[TBL] [Abstract][Full Text] [Related]
33. Outcome of pulmonary hypertension subjects transitioned from intravenous prostacyclin to oral bosentan.
Safdar Z
Respir Med; 2009 Nov; 103(11):1688-92. PubMed ID: 19539456
[TBL] [Abstract][Full Text] [Related]
34. Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics.
Siehr SL; Ivy DD; Miller-Reed K; Ogawa M; Rosenthal DN; Feinstein JA
J Heart Lung Transplant; 2013 May; 32(5):546-52. PubMed ID: 23453572
[TBL] [Abstract][Full Text] [Related]
35. [Ten years' experience in continuous intravenous epoprostenol therapy in severe pulmonary arterial hypertension].
Pombo Jiménez M; Escribano Subías P; Tello de Meneses R; Gómez-Sánchez MA; Delgado Jiménez J; Dalmau González-Gallarza R; Lázaro Salvador M; Hernández Rodríguez I; Tascón Pérez J; Sáenz de la Calzada C
Rev Esp Cardiol; 2003 Mar; 56(3):230-5. PubMed ID: 12622952
[TBL] [Abstract][Full Text] [Related]
36. Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children.
Hislop AA; Moledina S; Foster H; Schulze-Neick I; Haworth SG
Eur Respir J; 2011 Jul; 38(1):70-7. PubMed ID: 21177841
[TBL] [Abstract][Full Text] [Related]
37. Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial.
Hiremath J; Thanikachalam S; Parikh K; Shanmugasundaram S; Bangera S; Shapiro L; Pott GB; Vnencak-Jones CL; Arneson C; Wade M; White RJ;
J Heart Lung Transplant; 2010 Feb; 29(2):137-49. PubMed ID: 20022264
[TBL] [Abstract][Full Text] [Related]
38. Bosentan: new preparation. Pulmonary hypertension: an option before epoprostenol infusion.
Prescrire Int; 2005 Apr; 14(76):47-50. PubMed ID: 15875338
[TBL] [Abstract][Full Text] [Related]
39. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
Kylhammar D; Persson L; Hesselstrand R; Rådegran G
Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
[TBL] [Abstract][Full Text] [Related]
40. [Pulmonary arterial hypertension treated with prostacyclin or calcium blockers].
Andreassen AK; Geiran O; Madsen S; Hognestad A; Simonsen S
Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3393-6. PubMed ID: 14713978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]